Merck Healthcare Kgaa

Merck Healthcare Kgaa is a company in Darmstadt, Germany that has taken part in 10 EU-funded projects since 2021, receiving €799k in EU funding.

EU funding received€799k
EU projects10
As coordinator0
Running now7
First EU project2021
Latest project2026
CountryGermany
EU registration (PIC)900724735
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Merck Healthcare Kgaa's own share of each project, not the project's full budget.

  • Horizon 2020€506k · 2 projects
  • Horizon Europe€294k · 8 projects

Projects

10 EU-funded projects, newest first. Each links to the official record.

  • PFAROSAssociated partner

    Driving Sustainable Innovation to Minimise PFAS in European Healthcare

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

  • FORTIFYAssociated partner

    FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

  • BRIDGEAssociated partner

    Breakthrough Regulatory Innovation and Development throuGh sandbox Environments

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • PharmEcoAssociated partner

    Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing

    Horizon Europe · 2024–2030 · Project on CORDIS ↗

  • NHPigAssociated partner

    Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • VICT3RAssociated partner

    Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • trainLSEAssociated partner

    Interdisciplinary and intersectoral doctoral training programme at the Technische Universität Darmstadt in Life Science Engineering

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • CANCERNAPartner

    RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €294ktheir share
  • ALLODDPartner

    Allostery in Drug Discovery

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €253ktheir share
  • AGePOPPartner

    Drug Absorption in Geriatric Patients and Older People: a training network innovating drug development for the advanced age population

    Horizon 2020 · 2021–2024 · Project on CORDIS ↗

    €253ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA
  • animal and dairy science
  • artificial intelligence
  • civil society
  • data processing
  • data science
  • databases
  • governance
  • immunotherapy
  • leukemia
  • manufacturing engineering
  • melanoma
  • pathology
  • pathophysiology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime